Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A Longitudinal Toxicity over Time (ToxT) Analysis of Bortezomib When Added to Bendamustine-Rituximab (BR) in Previously Untreated High Risk (HR) Follicullar Lymphoma (FL) from in E2408 Hong, F., Evens, A. M., Novotny, P. J., Habermann, T. M., Advani, R. H., Gascoyne, R. D., Witzig, T. E., Quon, A., Ranheim, E. A., Dueck, A. C., Kahl, B. S., Thanarajasingam, G. AMER SOC HEMATOLOGY. 2018
View details for DOI 10.1182/blood-2018-99-117249
View details for Web of Science ID 000454842803182